The Global Topical Wound Agents Market Size to Grow from USD 1.9 Billion in 2023 to USD 3.7 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 6.89% during ...

Refractory dry eye in patients with systemic comorbidities can be challenging to manage because the underlying condition or ...

Rectally administered topical agents have demonstrated efficacy in the maintenance of distal colitis (DC) and proctitis and as they are rarely associated with significant blood drug levels, side ...

Tranexamic acid is an antifibrinolytic agent commonly used to reduce surgical blood loss in major surgeries, including joint replacement surgeries. [1,2] This prospective, double-blind, randomized ...

Please provide your email address to receive an email when new articles are posted on . Topical triple-agent fixed-dose combination had the best log-ratio for treatment success. It also proved to be ...

At a CAGR of 6.6% over the course of the projected year, the global topical wound agents industry size is anticipated to produce nearly US$ 3,520.0 million by 2033, up from US$ 1,856.6 million in 2023 ...

Plaque psoriasis is the most prevalent form of the disease. Unsightly skin can cause patients great anguish, raising their frustration with slow or ineffective therapies. This is the approach used by ...

One hundred and five patients scheduled for cataract surgery with topical anaesthesia were randomly allocated into 3 groups of 35 patients each to receive eye drops of lidocaine 2%, levobupivacaine ...

The topical wound agents market size is anticipated to exceed USD 1,856.6 million in 2023 and is likely to attain a valuation of USD 3,520.0 million by 2033. The topical wound agents market share is ...

The prevalence of chronic wounds, including venous ulcers and diabetic foot ulcers, is rising due to the implication of demographic and health factors such as the aging population, higher rates of ...